Merck & Co., Inc. (MRK - Get Report) is expected to report quarterly earnings of $1.05 a share on sales of $10.5 billion before the market opens Tuesday, April 30, based on a FactSet survey of 13 analysts.
In the same period a year ago, the company posted earnings of $1.05 a share on sales of $10 billion.
The stock has risen 0.2% since the company last reported earnings on Feb. 1.
Quarterly estimates have fallen less than 1 cent a share in the past month.
Merck is currently trading at a price-to-forward-earnings ratio of 15.8 based on the 12-month estimates of 15 analysts surveyed by FactSet.
Jim Cramer and the AAP team are watching the pharmaceuticals sector. To find out more about what stocks they like in the industry click here now to get more from Action Alerts PLUS.
Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.